🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and immune response to DEC-205/...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2013-07-30
Trial ID
NCT01834248
Treatments Being Tested
This phase I trial studies the side effects of DEC-205/NY-ESO-1 fusion prot...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2018-03-27
Trial ID
NCT03358719
This phase II trial studies the effect of a vaccine called CDX-1401 given w...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2014-04-09
Trial ID
NCT02129075
Treatments Being Tested
This study will look at the safety of the combination of three drugs (CDX-1...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-01
Trial ID
NCT02661100
Treatments Being Tested
The primary purpose of this study is to look at effects, good or bad, of co...
Status
Withdrawn
Location
Yale University
Start Date
2015-07
Trial ID
NCT02495636
The main purpose of this study is to examine the safety and tolerability of...
Status
Completed
Location
Yale Comprehensive Cancer Center
Start Date
2009-09
Trial ID
NCT00948961
Treatments Being Tested
This phase I trial studies the side effects and best schedule of vaccine th...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2012-03
Trial ID
NCT01522820
This is a study to determine the clinical benefit (how well the drug works)...
Status
Terminated
Location
California Pacific Medical Center Research Institute
Start Date
2015-04
Trial ID
NCT02413827
This randomized phase I/IIb trial studies side effects and best dose of ate...
Status
Completed
Location
Banner University Medical Center - Tucson
Start Date
2017-11-08
Trial ID
NCT03206047
This partially randomized phase I/IIb trial studies the side effects and be...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2014-10-10
Trial ID
NCT02166905